Brittle diabetes: long-term control with a portable, continuous, intravenous insulin infusion system.
作者信息
Bayliss J
出版信息
Br Med J (Clin Res Ed). 1981 Nov 7;283(6301):1207-9. doi: 10.1136/bmj.283.6301.1207.
Abstract
A young woman had severe brittle diabetes mellitus that was critically unmanageable with all conventional insulin treatment. Continuous subcutaneous and intramuscular infusions of insulin also failed to control her metabolic instability. Use of a continuous intravenous infusion, however, whereby a portable, variable-rate, battery-operated syringe pump delivered insulin through a subcutaneously tunnelled central venous catheter, resulted in good control. When she was receiving hourly intramuscular insulin injections (a mean of 778 IU daily) mean blood glucose concentrations had been 22.1 +/- 1.4 mmol/l (398 +/- 25 mg/100 microliters). After she had received the intravenous infusion for one month as an outpatient mean blood glucose concentration was 8.2 +/- 0.46 mmol/l (148 +/- 8 mg/100 microliters) and only 80 IU insulin daily was required. Follow-up after over five months of use showed that few complications had occurred. The system is simple to use and safe, and the diabetes had been stabilised such that she could enjoy a near-normal life style.
摘要
相似文献
1
Brittle diabetes: long-term control with a portable, continuous, intravenous insulin infusion system.
Br Med J (Clin Res Ed). 1981 Nov 7;283(6301):1207-9. doi: 10.1136/bmj.283.6301.1207.
2
Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
Br Med J (Clin Res Ed). 1981 Jan 31;282(6261):347-50. doi: 10.1136/bmj.282.6261.347.
3
Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 days.
Diabetologia. 1979 Jun;16(6):385-9. doi: 10.1007/BF01223159.
4
Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
Diabetes Care. 1983 Mar-Apr;6(2):105-11. doi: 10.2337/diacare.6.2.105.
5
Long-term continuous intraperitoneal insulin treatment in brittle diabetes.
Br Med J (Clin Res Ed). 1983 Jan 22;286(6361):255-6. doi: 10.1136/bmj.286.6361.255.
6
Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.
Br Med J. 1978 Jan 28;1(6107):204-7. doi: 10.1136/bmj.1.6107.204.
7
Long-term, ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients.
Diabetes Care. 1981 Mar-Apr;4(2):269-74. doi: 10.2337/diacare.4.2.269.
8
Long-term continuous subcutaneous insulin infusion in diabetics at home.
Lancet. 1979 Oct 27;2(8148):870-3. doi: 10.1016/s0140-6736(79)92686-2.
9
Evaluation of a portable insulin infusion pump for outpatient management of brittle diabetes.
Diabetes Care. 1979 Sep-Oct;2(5):421-4. doi: 10.2337/diacare.2.5.421.
10
[Diabetes therapy with continuous insulin infusion by a portable pump: metabolic effects of short-term treatment and long-term results in problem patients].
Acta Med Austriaca. 1982;9(5-6):205-13.
引用本文的文献
1
USE OF INHALED INSULIN IN A PATIENT WITH SUBCUTANEOUS INSULIN RESISTANCE SYNDROME: A RARE CONDITION.
AACE Clin Case Rep. 2019 Apr 25;5(3):e187-e191. doi: 10.4158/ACCR-2018-0493. eCollection 2019 May-Jun.
2
The treatment of unstable type I diabetes: conventional versus portable pump insulin administration.
Acta Diabetol Lat. 1983 Oct-Dec;20(4):363-70. doi: 10.1007/BF02581168.
3
Open-loop device Microjet MC 2 improves unstable diabetes, lowers the daily insulin requirement and reduces the excursions of plasma free insulin levels: comparison with a traditional intensive treatment.
J Endocrinol Invest. 1983 Jun;6(3):189-94. doi: 10.1007/BF03350606.
4
Brittle diabetes--present concepts.
Diabetologia. 1985 Aug;28(8):579-89. doi: 10.1007/BF00281992.
5
Implantable infusion pump management of insulin resistant diabetes mellitus.
Ann Surg. 1985 Sep;202(3):278-82. doi: 10.1097/00000658-198509000-00002.
6
Metabolic instability in type I diabetic patients. Studies on insulin absorption, hepatic production of metabolites and glucose counterregulation.
Acta Diabetol Lat. 1985 Jul-Sep;22(3):215-21. doi: 10.1007/BF02590772.
本文引用的文献
1
Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.
N Engl J Med. 1981 Aug 13;305(7):363-8. doi: 10.1056/NEJM198108133050702.
2
Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin.
Diabetologia. 1980;18(2):147-50. doi: 10.1007/BF00290492.
3
Insulin infusion systems, diabetic control, and microvascular complications.
Br Med J. 1980 Feb 9;280(6211):350-2. doi: 10.1136/bmj.280.6211.350.
4
Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
Br Med J (Clin Res Ed). 1981 Jan 31;282(6261):347-50. doi: 10.1136/bmj.282.6261.347.
5
A simple method for the determination of serum free insulin levels in insulin-treated patients.
Diabetes. 1973 Aug;22(8):590-600. doi: 10.2337/diab.22.8.590.
6
Technique for placement of a permanent home hyperalimentation catheter.
Surg Gynecol Obstet. 1976 Oct;143(4):634-6.
7
Five years' experience with a right atrial catheter for prolonged parenteral nutrition at home.
Surg Gynecol Obstet. 1976 Aug;143(2):205-8.
8
Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.
N Engl J Med. 1979 Mar 15;300(11):573-8. doi: 10.1056/NEJM197903153001101.
9
Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site.
Diabetologia. 1979 Aug;17(2):97-9. doi: 10.1007/BF01222209.
10
Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.
Br Med J. 1978 Jan 28;1(6107):204-7. doi: 10.1136/bmj.1.6107.204.
Zotero 插件